The stock of Geron Corporation (NASDAQ:GERN) decreased by -$0.03 on Monday to finish at $2.44, down -1.21 percent. The last five days have seen an average of 6,516,280 shares of common stock traded. 2 times new highs were reached in the current year, with a gain of $0.02. The average number of shares traded over the last 20 days was 5,270,955, while the average volume over the last 50 days totaled 4,830,772.
GERN stock dropped -23.27% since last month. On 08/22/23, the company’s shares reached a one-month low of $2.21. The stock touched a high of $3.84 on 01/04/23, after rallying from a low of $1.95 in 52 weeks. The price of GERN stock has risen by 0.83% or $0.02 this year, reaching a new high 2 times. Still, the stock price is down -36.46% from the 52-week high.
Insider Transactions
GERN stock investors should be aware that Geron Corporation (GERN) stock had its last reported insider trading activity 5 days ago on Aug 24. On Aug 24, Director O’Farrell Elizabeth G. acquired 6,607 shares at $2.28 each. This transaction resulted in the insider spending $15,064. On Aug 24, O’Farrell Elizabeth G. added 6,579 shares at a price of US$2.28. After the transaction, the insider now owns 26,220 shares. Director LAWLIS V BRYAN had earlier sold 35,000 shares on May 11 for $3.00 a share. The transaction was completed for $105,000.
Valuation Metrics
Beta for the stock is 0.85. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 2388.61, the price-to-book (PB) ratio of 4.44.
Financial Health
For the three months ended June 29, Geron Corporation’s quick ratio was 5.20, while its current ratio was 5.20, indicating its ability to pay off its debt. The company’s long-term debt to equity ratio for the quarter ending June 29 is 0.14, and the total debt to equity ratio is 0.17. Based on annual data, it had gross profit of $139.15 million and revenue of $0.6 million.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. GERN’s return on assets (ROA) during the last 12 months has been -54.20%. There was a -105.70% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was -84.20%.
Earnings Surprise
According to Geron Corporation’s quarterly financial report for the quarter that ended June 29. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $30000.0, while revenues fell by -133.33% to $20000.0. It was predicted that Geron Corporation’s quarterly earnings would be -$0.09, but it ended up being -$0.08, beating the consensus by -12.50%. EBITDA was -$54.67 million for the quarter. At the end of Geron Corporation’s most recent quarter ended June 29, its liabilities totaled 116.87 million, while its total debt was $55.93 million. Equity owned by shareholders amounts to $523.37 million.
Technical Picture
Here’s a quick look at Geron Corporation’s (GERN) price momentum from a technical perspective. As of 28 August, the RSI 9-day stood at 35.14%, suggesting the stock is Neutral, with a 96.28% historical volatility rate.
The stochastic %K and %D were 22.10% and 15.74% respectively, while the average true range (ATR) was 0.18. Based on the 14-day stochastic reading of 25.84%, the RSI (14) reading is 34.97%. On the 9-day MACD Oscillator, the stock is at -0.07, and the 14-day reading is at -0.25.
Analyst Ratings
In its analyst report released on March 28, 2023, Goldman began covering Geron Corporation (NASDAQ: GERN). The stock was rated as a Neutral by the brokerage firm. Analysts have assigned Geron Corporation (GERN) an Overweight rating. GERN is a stock that is recommended for selling by 0 brokerage firms, while 1 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 1 rate it overweight and 4 others recommend it as a buy.
What is GERN’s price target for the next 12 months?
The current consensus forecast for the stock is between $4.00 and $6.00, with a median target price of $5.00. In analyzing these forecasts, the average price target given by analysts for Geron Corporation (GERN) is $4.83.
